Technology provides procedure efficiencies for congenital heart disease patients

FDA says do not drink ‘Real Water’ brand alkaline water
30 April 2021
New wearable sensor tracks children’s suffering with eczema, and adults with itch symptoms
30 April 2021

Technology provides procedure efficiencies for congenital heart disease patients

An analysis of a new international registry reveals benefits of using a longer covered stent for interventional procedures in congenital heart disease patients with Sinus Venosus Atrial Septal Defect (SVASD). The study was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.

Comments are closed.